RBBP5 and glioblastoma: In glioblastoma, CSCs exhibit low TLR4 expression, which enhances retinoblastoma-binding protein 5 (RBBP5) function as a core activator of stemness transcription factors, thereby promoting CSC self-renewal and reinforcing CSC properties.